Thr202Ala in thyA is a marker for the Latin American mediterranean lineage of the Mycobacterium tuberculosis complex rather than Para-aminosalicylic acid resistance

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 11, 2010, Pages 4794-4798

  Feuerriegel, Silke ^a   Köser, Claudio ^b   Trübe, Leona ^a   Archer, John ^c   Gerdes, Sabine Rüsch ^a   Richter, Elvira ^a   Niemann, Stefan ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINOSALICYLIC ACID; BACTERIAL PROTEIN; BIOLOGICAL MARKER; PROTEIN THYA; THREONINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; GENETIC VARIABILITY; GENOME ANALYSIS; GERMANY; GROWTH CURVE; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINOSALICYLIC ACID; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOME, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78049276290     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00738-10     Document Type: Article

References (20)

1. Allix-Béguec, C., D. Harmsen, T. Weniger, P. Supply, and S. Niemann. 2008. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 46:2692-2699.
2. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
3. Cox, H., S. Kalon, S. Allamuratova, V. Sizaire, Z. Tigay, S. Rüsch-Gerdes, H. Karimovich, Y. Kebede, and C. Mills. 2007. Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures. PLoS One 2:e1126. (Pubitemid 351594020)
4. Deutsches Institut für Normung e.V. 2009. Norm 58943, Part 8. Methods for the determination of susceptibility of tubercle bacilli to chemotherapeutic agents. Deutsches Institut für Normung, Berlin, Germany.
5. Dye, C., B. Williams, M. Espinal, and M. Raviglione. 2002. Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science 295:2042-2046. (Pubitemid 34229458)
6. Homolka, S., C. Köser, J. Archer, S. Rüsch-Gerdes, and S. Niemann. 2009. Single-nucleotide polymorphisms in Rv2629 are specific for Mycobacterium tuberculosis genotypes Beijing and Ghana but not associated with rifampin resistance. J. Clin. Microbiol. 47:223-226.
7. Ioerger, T., S. Koo, E. No, X. Chen, M. Larsen, W. J. Jacobs, M. Pillay, A. Sturm, and J. Sacchettini. 2009. Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS One 4:e7778.
8. Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914.
9. Kent, P. T., and G. P. Kubica. 1985. Public health mycobacteriology. A guide for the level III laboratory. Centers for Disease Control and Prevention, Atlanta, GA.
10. Kurtz, S., A. Phillippy, A. Delcher, M. Smoot, M. Shumway, C. Antonescu, and S. Salzberg. 2004. Versatile and open software for comparing large genomes. Genome Biol. 5:R12.
11. Mathys, V., R. Wintjens, P. Lefevre, J. Bertout, A. Singhal, M. Kiass, N. Kurepina, X. Wang, B. Mathema, A. Baulard, B. Kreiswirth, and P. Bifani. 2009. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 53:2100-2109.
12. Mitnick, C., J. Bayona, E. Palacios, S. Shin, J. Furin, F. Alcántara, E. Sánchez, M. Sarria, M. Becerra, M. Fawzi, S. Kapiga, D. Neuberg, J. Maguire, J. Kim, and P. Farmer. 2003. Community-based therapy for multidrugresistant tuberculosis in Lima, Peru. N. Engl. J. Med. 348:119-128.
13. Oelemann, M. C., R. Diel, V. Vatin, W. Haas, S. Rusch-Gerdes, C. Locht, S. Niemann, and P. Supply. 2007. Assessment of an optimized mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing system combined with spoligotyping for population-based molecular epidemiology studies of tuberculosis. J. Clin. Microbiol. 45:691-697.
14. Plinke, C., H. Cox, N. Zarkua, H. Karimovich, K. Braker, R. Diel, S. Rüsch-Gerdes, S. Feuerriegel, and S. Niemann. 2010. embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation. J. Antimicrob. Chemother. 65:1359-1367.
15. Rengarajan, J., C. Sassetti, V. Naroditskaya, A. Sloutsky, B. Bloom, and E. Rubin. 2004. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria. Mol. Microbiol. 53:275-282.\
16. Satti, H., K. Seung, S. Keshavjee, and J. Furin. 2008. Extensively drug-resistant tuberculosis, Lesotho. Emerg. Infect. Dis. 14:992-993.
17. Supply, P., C. Allix, S. Lesjean, M. Cardoso-Oelemann, S. Rusch-Gerdes, E. Willery, E. Savine, P. de Haas, H. van Deutekom, S. Roring, P. Bifani, N. Kurepina, B. Kreiswirth, C. Sola, N. Rastogi, V. Vatin, M. C. Gutierrez, M. Fauville, S. Niemann, R. Skuce, K. Kremer, C. Locht, and D. van Soolingen. 2006. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J. Clin. Microbiol. 44:4498-4510.
18. van Embden, J. D., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, T. M. Shinnick, et al. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31: 406-409.
19. Weniger, T., J. Krawczyk, P. Supply, S. Niemann, and D. Harmsen. 2010. MIRU-VNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria. Nucleic Acids Res. 38(Suppl.):W326-W331.
20. Zhang, Z., Y. Zhao, Z. Li, H. Jia, Y. Liu, X. Chen, Z. Liu, B. Du, A. Xing, and Y. Ma. 2007. Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi 30:683-685.